PMID: 34380882
He said future research should assess the economic impact of combined SGLT2 and GLP-1 therapy in different settings
Studies have noted higher rates of gastrointestinal disorders, hypotension, syncope, kidney stones (nephrolithiasis), interstitial nephritis, and drug-induced pancreatitis
Here, we present an ordinary differential equation (ODE) based dynamic model to describe the dynamic response of Nrf2, Keap1, Srxn1 and GSH to oxidative stress caused by the soft-electrophile diethyl maleate (DEM)
Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and stimulates brainstem receptors involved in nausea Nausea affects at least 10% of patients and is dose-dependent, often improving after several weeks of continued treatment Dietary modifications, smaller frequent meals, and gradual dose escalation help reduce gastrointestinal side effects Severe persistent vomiting, inability to retain fluids, or severe abdominal pain warrant immediate medical assessment Rare serious complications include pancreatitis, gallbladder disease, and dehydration-related kidney problems requiring urgent review Table of Contents Does Ozempic Make You Feel Sick